Project Background:
The client is one of the well-known global pharmaceutical enterprises, leveraging its profound expertise in the pharmaceutical field to provide innovative treatment solutions for patients worldwide, particularly excelling in areas such as cardiovascular diseases, oncology, diabetes, and central nervous system disorders. While the insulin market is relatively mature overseas, the continued increase in the global aging population and the number of diabetes patients indicates ongoing growth in this niche sector. It is forecasted that by 2030, the domestic market capacity will also reach several hundred billion RMB. A compliant quality management system is fundamental in ensuring patient safety and health, and it also embodies the company's social value.
Project Info.:
Project name:Insulin aseptic filling production line project
Product type:Insulin
Facility type:Expansion project
Project-driven:Compliance with international regulations, Quality Safety, Rapidity
Service Scope:
Project design & quality management
Development of C&Q validation strategies
Risk analysis and DQ for facility systems
Risk analysis and DQ for process equipment
Guidance and review of validation for factory facility systems and process equipment
C&Q Compliance according to ISPE Guideline
Project Challenges:
Risk analysis for multiple products manufacture in shared facilities
Compliance with the latest version of EU Annex 1
Simplification of personnel configuration and diversification of facility systems
Our Capabilities:
Project experience with NMPA, EMA, and FDA standards
Compliance monitoring throughout project execution
Capability enhancement for client's project team
Application of the new version of ISPE C&Q guidelines